1. Introduction {#sec1}
===============

Aggregation of amyloidogenic proteins leads to many human pathologies, including a progressive neurodegenerative disorder, Alzheimer's disease (AD).^[@ref1]^ AD is the most common type of dementia that affects daily living through depression, memory loss, apathy, anxiety, and cognitive decline. Current figures estimated that around 50 million people are living with dementia worldwide, and it is going to increase to 152 million by 2050.^[@ref2]^ A number of people affected by dementia have been increasing rapidly, and it is predicted that, for every 3 s, a new case of dementia has been reported worldwide. Various factors such as age,^[@ref3]^ family history,^[@ref4]^ and heredity^[@ref5]^ account for the development of AD. Among these, age is the greatest risk factor for AD as the prevalence of the disease increases with the increasing age. The percentage of people affected with dementia increases with age as seen from the statistical data: 3% of people age 65--74, 17% of people age 75--84, and 32% of people age 85 years or older. The current annual cost of treatment of dementia has been estimated to be \$1trillion, and this number is likely to double by 2030. The statistical data clearly indicates that AD poses to be a challenge to the health care system worldwide. Regrettably, to date, the pharmacological treatments so discovered are still unsatisfactory. This leads to a huge socioeconomic burden on the global healthcare and medical system, indicating that urgent steps should be taken for the development of new drug candidates for the treatment of AD.

Although the molecular root of AD is not clearly known, the previous literature highlighted that dynamic and transient amyloid-β (Aβ) oligomers are more toxic to cells than monomers and fibrils and play a key role in the pathology of AD.^[@ref6]^ Aβ results from sequential cleavage of AβPP (a transmembrane precursor protein) by β- and γ-secretases via the amyloidogenic pathway. The Aβ peptide so formed undergoes misfolding, which results in the appearance of β-sheet structures in the conformational ensemble of Aβ. The appearance of β-sheet structures ultimately leads to the self-association of peptide monomers to form toxic species.^[@ref7]^ A recent study highlighted the key role of heterogeneous amyloid oligomers in various protein misfolding diseases.^[@ref8]^

A huge library that includes small molecules,^[@ref9]^ nanoparticles,^[@ref10]^ degrading enzymes,^[@ref11]^ peptides and peptidomimetics,^[@ref12]^ and antibodies^[@ref13]^ as anti-aggregation entities have been reported in the literature. Among these, small molecules play an indispensable role against Aβ~42~ aggregation.^[@ref14]^ A number of small molecules, *e.g.*, CT1812,^[@ref15]^ E2609,^[@ref16]^ ID1201,^[@ref17]^ AR1001,^[@ref18]^ APH-1105,^[@ref19]^ CNP520,^[@ref20]^*etc.*, are in phase II/III clinical trials. Taking into account the importance of small molecules as potent drug candidates for AD, we have recently reported a series of mono-triazole-based compounds **4(a**--**x)** as multitarget-directed ligands (MTDLs) against AD.^[@ref21]^ Among the synthesized library, compound **4v** featuring an *o*-I moiety was evaluated as the most effective inhibitor of Aβ~42~ aggregation (78.02% inhibition) with an IC~50~ value of 4.578 ± 0.109 μM. Compound **4v** disaggregates the preformed Aβ~42~ fibrils as effectively as the standard compound curcumin. Additionally, **4v** suppresses the generation of reactive oxygen species (ROS) in copper-ascorbate redox cycling by maintaining the copper in the redox-dormant state. Further, **4v** notably inhibited the Cu^2+^-induced Aβ~42~ aggregation and disassembled the preformed Cu^2+^-induced Aβ~42~ fibrils. Importantly, **4v** did not show cytotoxicity in SH-SY5Y cells and was able to rescue the cells from the toxicity induced by Aβ~42~ aggregates. The antagonist effect of **4v** against Aβ~42~ aggregation was established via experimental studies; however, the atomic-level details of the mechanism of action of **4v** against Aβ~42~ aggregation remain largely unknown.

In this regard, molecular dynamics (MD) simulations in explicit solvent have been performed to investigate the mechanism of action of **4v** against Aβ~42~ aggregation and disaggregation of preformed Aβ~42~ fibrils. It has been found that **4v** binds at the central hydrophobic core (CHC) region (a crucial player in Aβ~42~ peptide aggregation) of the Aβ~42~ monomer and binds at the even edge (chain E) of the Aβ~42~ protofibril structure. Compound **4v** significantly preserved the helical content and reduces the β-sheet content in the Aβ~42~ monomer. In the Aβ~42~ protofibril structure, **4v** enhanced the coil content and lowers the aggregation-prone β-sheet conformation. Hydrogen bonding, hydrophobic contacts, and π--π interactions contribute to the effective binding of **4v** with the Aβ~42~ peptide. The results obtained would provide a platform in designing new triazole-based scaffolds as effective inhibitors against Aβ~42~ aggregation.

2. Computational Details {#sec2}
========================

2.1. Initial Structures of Aβ~42~ Monomer, Aβ~42~ Protofibril, and **4v** {#sec2.1}
-------------------------------------------------------------------------

ChemDraw Ultra 12.0 software was used to draw the chemical structure of compound **4v** ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a). Various three-dimensional structures of the Aβ monomer and fibril have been characterized by electron microscopy,^[@ref22]^ electron paramagnetic resonance,^[@ref23]^ solid-state NMR,^[@ref24]^ and X-ray diffraction.^[@ref25]^ The NMR structure of the full-length Aβ~42~ monomer (PDB ID: 1IYT)^[@ref26]^ was chosen as the starting structure in the present study ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b). The structure consists of 42 amino acid residues with two helical regions, helix I (Ser8--Gly25) and helix II (Lys28--Gly38), connected by a regular type-I β-turn (Ser26--Asn27). To explore the inhibitory mechanism of various anti-aggregation agents, the Aβ~42~ monomer structure (PDB ID: 1IYT) was used in a number of studies.^[@ref27]^ A pentameric structure of the Aβ~42~ protofibril (PDB ID: 2BEG)^[@ref28]^ was used in the present study ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}c). Various recent reports have considered the pentameric model, 2BEG, as a suitable model system for computational studies.^[@ref29]^ In the pentameric model of the Aβ~42~ protofibril, the disordered N-terminal residues ranging from Asp1 to Lys16 are missing for each chain and the remaining residues, Leu17 to Ala42, form a β-strand--bend−β-strand motif. In the Aβ~42~ protofibril structure, β1 (residues Leu17--Ser26) and β2 (residues Ile31--Ala42) are the two β-strands that are connected by a bend region (Asn27--Ala30). The single subunit of the Aβ~42~ protofibril comprises five identical peptide chains with residues Leu17--Ala42 and is labeled as chains A--E.

![The chemical structure of **4v**, Aβ~42~ monomer (PDB ID: 1IYT) structure, and Aβ~42~ protofibril (PDB ID: 2BEG) structure are shown in panels (a), (b), and (c), respectively. The five peptide chains (A--E) of the Aβ~42~ protofibril structure are shown in yellow, green, blue, cyan, and red, respectively, with N- and C-termini labeled.](ao0c01825_0001){#fig1}

2.2. MD Simulations Setup and Analysis {#sec2.2}
--------------------------------------

The simulations have been extensively used to study the binding mechanism and key interactions between the protein--ligand complex.^[@ref27],[@ref29],[@ref30]^ In the present study, the GROningen MAchine for Chemical Simulations (GROMACS) 5.0.5 package^[@ref31]^ with optimized potential for liquid simulations all-atom (OPLS-AA) force field^[@ref32]^ has been used to perform a total of 1.6 μs simulations. A number of studies employed the OPLS-AA force field to investigate Aβ fragments aggregation in explicit water.^[@ref33]^ Moreover, the OPLS-AA force field effectively represents the halogen atoms in aryl halides to account for the halogen bonding.^[@ref34]^

The AutoDock 4.2 software has been employed for molecular docking.^[@ref35]^ In the present study, four systems were constructed (Aβ~42~ monomer, docked complex of Aβ~42~ monomer with **4v**, Aβ~42~ protofibril, and docked complex of Aβ~42~ protofibril with **4v**) to understand the atomic-level details of the mechanism of action of **4v** against Aβ~42~ aggregation. The simulation details are listed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}. The Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex have been simulated in a cubic box with dimensions 7.4 nm × 7.4 nm × 7.4 nm with at least 1.0 nm distance between the Aβ~42~ monomer and the periodic box boundary.^[@ref36]^ On the other hand, the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex have been kept in a cubic box with dimensions 10.4 nm × 10.4 nm × 10.4 nm and the minimum distance between the protein and the periodic box boundary was kept at 2.8 nm.^[@ref37]^ The Aβ~42~ peptide in all the four systems was protonated based on the physiological pH (7.4). The N-terminal and C-terminal of the Aβ~42~ peptide were kept protonated and deprotonated, respectively. All the four systems were solvated by using the simple point charge (SPC) water model^[@ref38]^ and were neutralized by adding sufficient Na^+^ ions as per the literature.^[@ref39]^ The particle mesh Ewald (PME) method was used to calculate the long-range electrostatic interactions, and the cutoff for short-range van der Waals interactions was kept at 1.0 nm.^[@ref40]^ The LINCS algorithm with an integration time step of 2 fs was used to constraint the bond lengths.^[@ref41]^ The equilibration of the systems was done under the NVT ensemble for 1 ns at 300 K followed by the second phase of equilibration under the NPT ensemble for 1 ns at 1 bar. In all MD simulations, the temperature was maintained at 300 K using a modified Berendsen thermostat^[@ref42]^ and the pressure was maintained at 1 bar using a Parrinello--Rahman barostat.^[@ref43]^ All the four systems were simulated for a time period of 200 ns, and the trajectories were saved at every 10 ps time interval. After the completion of simulations, GROMACS tools along with visual molecular dynamics (VMD),^[@ref44]^ PyMOL,^[@ref45]^ and the dictionary of secondary structure of proteins (DSSP) program^[@ref46]^ were used for the analysis of the trajectories. The MD ensemble was clustered using a root-mean-square deviation (RMSD)-based cluster analysis over backbone atoms with a cutoff of 0.20 nm.^[@ref47]^ The RMSD, radius-of-gyration (*R*~g~), and root-mean-square fluctuation (RMSF) analyses were performed using GROMACS tool "gmx rms", "gmx rmsf", and "gmx gyrate", respectively, to elucidate the structural stability of the Aβ~42~ peptide in all the four systems. The tertiary contacts between the residues were determined using the GROMACS tool "gmx mdmat". The repeat simulations with different initial velocities have been performed for the Aβ~42~ monomer and Aβ~42~ protofibril to check the reproducibility of the simulation data.

###### Details Regarding the Model System, Simulation Setup, Simulation Time, Box Dimension, and Number of Water Molecules in the Simulation Box

  model system                                         simulation time (ns)[c](#t1fn3){ref-type="table-fn"}   box dimensions (nm)   number of water molecules in the simulation box
  ---------------------------------------------------- ------------------------------------------------------ --------------------- -------------------------------------------------
  Aβ~42~ monomer[a](#t1fn1){ref-type="table-fn"}       200 × 3                                                7.4 × 7.4 × 7.4       13,527
  Aβ~42~ monomer--**4v** complex                       200                                                    7.4 × 7.4 × 7.4       12,734
  Aβ~42~ protofibril[b](#t1fn2){ref-type="table-fn"}   200 × 3                                                10.4 × 10.4 × 10.4    37,587
  Aβ~42~ protofibril--**4v** complex                   200                                                    10.4 × 10.4 × 10.4    37,100

Aβ~42~ monomer (PDB ID: 1IYT).

Aβ~42~ protofibril (PDB ID: 2BEG).

The simulations were performed with the OPLS-AA force field and SPC water model. The triplicate simulations of 200 ns each were performed for two systems (Aβ~42~ monomer and Aβ~42~ protofibril).

2.3. Binding Free Energy Calculations and Free Energy Landscape (FEL) Analysis {#sec2.3}
------------------------------------------------------------------------------

Molecular mechanics Poisson--Boltzmann surface area (MM-PBSA) analysis has been routinely used to evaluate the binding free energy between the protein and ligand^[@ref48]^ by using the g_mmpbsa tool.^[@ref49]^ In this method, the binding free energy including electrostatic interactions, van der Waals interactions, polar solvation energy, and non-polar solvation energy were measured. However, the contribution of conformational entropy has been ignored in accordance with a previous study.^[@ref50]^ In the MM-PBSA method, the binding free energy was calculated using the following equation:where Δ*E*~MM~ = Δ*E*~vdW~ + Δ*E*~elec~ and Δ*G*~solv~ = Δ*G*~ps~ + Δ*G*~nps~*.*

The FEL analysis was performed in accordance with our previously reported study in which the MD simulations were carried out to comprehend the effect of di-triazole-based compound **6n** on the structure and stability of monomeric Aβ~42~ and a pentameric protofibril structure of Aβ~42~.^[@cit29a]^

3. Results and Discussion {#sec3}
=========================

Recently, we have reported novel mono-triazole derivatives **4(a**--**x)** as MTDLs against AD.^[@ref21]^ Among the designed library, compound **4v** featuring an *o*-I moiety was evaluated as the most effective inhibitor of self-induced Aβ~42~ aggregation, disaggregates preformed Aβ~42~ protofibrils, exhibited excellent metal chelating ability, prevents the ROS generation, and remarkably inhibited Cu^2+^-induced Aβ~42~ aggregation. Importantly, **4v** did not show cytotoxicity in SH-SY5Y cells and rescued the cells from Aβ~42~ aggregate-mediated toxicity. The molecular docking analysis highlighted that **4v** binds with the Aβ~42~ monomer and Aβ~42~ protofibril with binding energies of −5.12 and −6.54 kcal/mol, respectively. Motivated by the promising results obtained in the *in vitro* investigation, we have further explored the underlying inhibitory mechanism of **4v** against Aβ~42~ aggregation and disaggregation of preformed Aβ~42~ fibrils using MD simulations. In this context, extensive atomistic MD simulations of four systems, Aβ~42~ monomer, Aβ~42~ monomer--**4v**, Aβ~42~ protofibril, and Aβ~42~ protofibril--**4v**, were carried out in the present study.

3.1. MD Simulation of Aβ~42~ Monomer and Aβ~42~ Monomer--**4v** Complex {#sec3.1}
-----------------------------------------------------------------------

### 3.1.1. Validation of Computational Data with Experimental NMR Data {#sec3.1.1}

The simulation data was compared with the experimental NMR data in order to validate the conformational ensembles generated by MD. The chemical shift (δ~sim~) values for Cα and Cβ atoms of the Aβ~42~ monomer was calculated by the SHIFTX2 program.^[@ref51]^ The *J*-coupling (^3^*J*~NH--Hα~) constants were calculated by evaluating the dihedral angles ϕ and ψ of amino acids for the MD ensemble using the Karplus equation.^[@ref52]^ The experimental chemical shift (δ~exp~)^[@ref53]^ and computational chemical shift (δ~sim~) for Cα and Cβ of the Aβ~42~ monomer showed high correlations (*R* = 0.96 and *R* = 0.99) ([Figure S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)a,b). Further, the ^3^*J*~NH--Hα~ values obtained from MD data of the Aβ~42~ monomer were compared with experimental ^3^*J*~NH--Hα~ values*.* The average value of computational ^3^*J*~NH--Hα~ for the Aβ~42~ monomer was 6.98 Hz, which was nearly the same as the experimental ^3^*J*~NH--Hα~ value (6.80 Hz)^[@ref54]^ ([Figure S1c](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)). The above results highlighted a consistency between the simulation and experimental data.

### 3.1.2. Effect of **4v** on the Structural Stability of Aβ~42~ Monomer {#sec3.1.2}

To scrutinize the effect of **4v** on the structural stability of the Aβ~42~ monomer, the conformational clustering analysis was performed ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The representative member of the most-populated conformational cluster of the Aβ~42~ monomer--**4v** complex displayed hydrophobic contacts between **4v** and Val12, Gln15, Lys16, Phe19, Ile31, Ile32, Met35, Val36, and Gly37 residues of the Aβ~42~ monomer ([Figure S2](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)). In addition, a hydrogen bond (0.25 nm) was observed between the ---C=O group of the ester of **4v** and the backbone NH of Gly37. Further, the conformational parameters, RMSD and RMSF, were evaluated for the Aβ~42~ monomer in the absence and presence of **4v** ([Figure S3](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)). The average value of the RMSD obtained for the Aβ~42~ monomer--**4v** complex was lower (1.07 nm) than Aβ~42~ alone (1.14 nm), as seen in [Figure S3a](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf). A similar trend was observed in the RMSF ([Figure S3b](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)) of the Aβ~42~ monomer--**4v** complex (0.59 nm) and Aβ~42~ monomer (0.63 nm). The lower RMSD and RMSF values for the Aβ~42~ monomer--**4v** complex point toward the structural stabilization of the Aβ~42~ monomer in the presence of **4v**. Further, the RMSD pattern obtained for repeat simulations 2 and 3 are analogous to that for simulation 1 of the Aβ~42~ monomer ([Figure S4](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)), indicating the reproducibility of MD results.

![The representative conformations of the most-populated clusters of the (a) Aβ~42~ monomer and (b) Aβ~42~ monomer--**4v** complex are shown in the cartoon representation with the percentage population of corresponding clusters.](ao0c01825_0006){#fig2}

### 3.1.3. Effect of **4v** on the Conformational Transition of Aβ~42~ Monomer {#sec3.1.3}

The conformational ensemble of the Aβ~42~ monomer in the absence and presence of **4v** was analyzed using DSSP analysis. The secondary structure component statistics indicated that the Aβ~42~ monomer attained 22.5 ± 2.8% coil, 9.0 ± 2.9% β-sheet, 19.2 ± 3.7% bend, 24.2 ± 1.4% turn, and 27.0 ± 5.1% helix conformations ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). The Aβ~42~ monomer sampled only 9.0 ± 2.9% β-sheet conformation; however, the presence of the aggregation-prone β--sheet conformation highlighted conformation conversion of the Aβ~42~ monomer that is consistent with the reported experimental results.^[@ref55]^ A similar percentage of secondary structure components for the Aβ~42~ monomer was obtained in repeat simulations 2 and 3 ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)), indicating the reproducibility of the MD simulations.

![The secondary structure component statistics for the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex is shown. The standard errors of the mean were calculated by dividing the simulation data into four long, non-overlapping blocks.](ao0c01825_0007){#fig3}

On the other hand, for the Aβ~42~ monomer--**4v** complex, the percentages of coil, β-sheet, bend, turn, and helix were 23.2 ± 1.6%, 3.0 ± 1.4%, 22.5 ± 2.2%, 20.7 ± 2.1%, and 33.0 ± 2.9%, respectively ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). The DSSP analysis highlighted that the helical content increases and β-sheet decreases considerably for the Aβ~42~ monomer in the presence of **4v**. Thus, **4v** retard the conformation conversion of the Aβ~42~ monomer from helical to β-sheet conformation (aggregation-prone conformation). The structural changes in the Aβ~42~ monomer in the absence and presence of **4v** were evaluated at different time frames (0, 50, 100, 150, and 200 ns), as seen in [Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}. The visual inspection of the Aβ~42~ monomer trajectory revealed that the L-shaped structure lost its helical content and attained the irregular U-shaped structure in the absence of **4v** ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a). On the contrary, **4v** stays near the CHC region of the Aβ~42~ monomer throughout the simulation and resisted the folding of the peptide, therefore sustained its native helical structure. The snapshot at 200 ns for the Aβ~42~ monomer indicates the conformation conversion from helix to random coil ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}a). It has been observed that **4v** enters inside the folded structure of the Aβ~42~ monomer at 50 ns and continues to remain inside until the end of the simulation ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}b). As a result, the Aβ~42~ monomer sampled a higher helical content and lower coil content in the presence of **4v**.

![The snapshots of MD trajectory at different time points for the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex are shown in panels (a) and (b), respectively. The Aβ~42~ monomer is shown in cartoon representation, and **4v** is shown in stick representation.](ao0c01825_0008){#fig4}

The per-residue secondary structure analysis was performed for the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). The results highlighted the increase in helical content in residues spanning the regions Asp1--Glu3, Arg5--Phe19, and Ser26--Ile31 of the Aβ~42~ monomer--**4v** complex as compared to the Aβ~42~ monomer ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}a). On the other hand, a significant loss in β-sheet percentage in His14, Val18, Ser26, Lys28, Gly29, Gly33, and Leu34 residues of the Aβ~42~ monomer in the presence of **4v** was observed ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}b). Overall, the per-residue secondary structure analysis indicates that **4v** stabilizes the Aβ~42~ monomer into its native helical conformation and retards the conformational conversion to the β-sheet secondary structure.

![The per-residue helix and β-sheet percentage in the Aβ~42~ monomer (red) and Aβ~42~ monomer--**4v** complex (blue) is shown in panels (a) and (b), respectively.](ao0c01825_0009){#fig5}

### 3.1.4. Binding Free Energy Calculations Using the MM-PBSA Method {#sec3.1.4}

The binding free energy calculated by the MM-PBSA method revealed an energetically favorable process with *ΔG*~binding~ = −44.9 ± 3.3 kcal/mol for the Aβ~42~ monomer--**4v** complex ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). The non-bonded van der Waals interactions (*ΔE*~vdw~ = −26.7 ± 1.7 kcal/mol) and non-polar solvation energy (*ΔG*~nps~ = −21.7 ± 2.7 kcal/mol) favor the binding of **4v** with the Aβ~42~ monomer. Further, the binding free energy contribution of each residue of the Aβ~42~ monomer--**4v** complex was analyzed ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}). It was observed that Gln15, Lys16, Phe19, Phe20, Glu22, and Asp23 residues of Aβ~42~ contribute the maximum in the binding free energy between the Aβ~42~ monomer and **4v**. The negative binding free energy observed for the above residues confirms that **4v** binds in the CHC region of the Aβ~42~ monomer. **4v** binds strongly to Lys16, which is known to play a key role in Aβ~42~ aggregation.^[@ref56]^

![The binding free energy (kcal/mol) contribution of each residue of the Aβ~42~ monomer in the Aβ~42~ monomer--**4v** complex is shown in panel (a). A snapshot of the Aβ~42~ monomer--**4v** complex depicting residues with high affinity for **4v** is shown. Various components of the binding free energy of the Aβ~42~ monomer--**4v** complex are listed in panel (b).](ao0c01825_0010){#fig6}

In 2015, Kumar et al.^[@ref57]^ highlighted that Phe19 and Phe20 are positioned favorably for π--π stacking in the mature fibril and these interactions provide structural stability to amyloid aggregates. Thus, designing ligands that can target this structural stacking will be able to effectively modulate Aβ~42~ aggregation.^[@ref57]^ In the present study, the maximum contribution of Phe19 and Phe20 of the Aβ~42~ monomer in binding to **4v** clearly demonstrates the non-availability of these residues for π--π interactions, which in turn highlight a lower aggregation tendency of Aβ~42~ in the presence of **4v**. Overall, the computational analysis performed in the present study advances our understanding of the experimentally observed inhibition of Aβ~42~ aggregation by **4v**. The Thioflavin T (ThT) fluorescence and transmission electron microscopy (TEM) assay indicated a significant decrease in the Aβ~42~ fibril formation in the presence of **4v**.^[@ref21]^

### 3.1.5. Impact of **4v** on the FEL of Aβ~42~ Monomer {#sec3.1.5}

The FEL as a function of principal components, PC1 and PC2, was plotted to investigate the conformational changes in the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}). A single minimum energy basin was observed for the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex. The conformation, *S1*, for the Aβ~42~ monomer and conformations (*S1* and *S2*) for the Aβ~42~ monomer--**4v** complex were extracted corresponding to the energy minima. To get a clear view of the impact of **4v** on the conformational transition of the Aβ~42~ monomer, the secondary structure analyses were done corresponding to the conformations extracted for the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}). In the Aβ~42~ monomer, the minimum energy conformation *S1* has the population percentages of coil, β-sheet, bend, turn, and helix as 13, 20, 26, 24, and 17%, respectively. On the other hand, in the Aβ~42~ monomer--**4v** complex, the minimum energy conformations *S1* and *S2* had an increase in coil content (18 and 17%) and sizable augmentation in the helix content (35 and 49%) as compared to the Aβ~42~ monomer. There was a considerable decrease in β-sheet content (5%) in the Aβ~42~ monomer--**4v** complex as compared to the Aβ~42~ monomer (20%). The FEL analyses were consistent with the secondary structure analysis, which clearly highlighted that **4v** retards the conformational transition of the Aβ~42~ monomer into the aggregation-prone β-sheet conformation.

![The FEL of the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex is shown in panels (a) and (b), respectively. The snapshots corresponding to the minimum free energy basins are shown in the cartoon representation. The blue region represents the minimum free energy basin with lowest energy conformations, whereas the orange region represents the higher energy basin with least populated conformations. The secondary structure component statistics for the minimum energy conformations obtained in the FEL of the Aβ~42~ monomer and Aβ~42~ monomer--**4v** complex is listed in panel (c).](ao0c01825_0011){#fig7}

3.2. MD Simulation of Aβ~42~ Protofibril and Aβ~42~ Protofibril-**4v** Complex {#sec3.2}
------------------------------------------------------------------------------

### 3.2.1. Validation of Computational Data with Experimental NMR Data {#sec3.2.1}

The NMR chemical shifts for Cα and Cβ atoms of the Aβ~42~ protofibril obtained from MD simulations (δ~sim~) displayed excellent correlations (*R* = 0.99 and *R* = 0.98) with the experimental values (δ~exp~) ([Figure S5](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)a,b). Additionally, the average value of computational ^3^*J*~NH--Hα~ was noted to be 8.20 Hz as compared to the experimental ^3^*J*~NH--Hα~ value (9.15 Hz)^[@ref58]^ ([Figure S5c](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)). In 2013, Chong et al. reported the computational ^3^*J*~NH--Hα~ value of 7.7 Hz for the Aβ~42~ monomer and compared it with the experimental ^3^*J*~NH--Hα~ value (6.9 Hz).^[@ref59]^ The above data suggested a good qualitative agreement between simulation and experimental values.

### 3.2.2. Effect of **4v** on the Conformational Ensemble of Aβ~42~ Protofibril {#sec3.2.2}

The association of the monomeric Aβ~42~ peptide forms toxic oligomers, which eventually lead to the formation of fibrillar structures.^[@ref60]^ To understand the molecular mechanism of experimentally observed disaggregation of preformed Aβ~42~ fibrils by **4v**,^[@ref21]^ MD simulations of the docked complex of Aβ~42~ protofibril--**4v** were performed. The representative members of the most-populated clusters obtained by clustering analysis for the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex are shown in [Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}. Cluster 1 of the Aβ~42~ protofibril has 23.3% population and represents a stable protofibril structure ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}a), whereas cluster 1 of the Aβ~42~ protofibril--**4v** complex was more populated (40.8%) with distorted protofibril structures ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}b). The key interactions of **4v** with Aβ~42~ protofibril in the most-populated cluster of the Aβ~42~ protofibril--**4v** complex were analyzed ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). The oxygen atom of a ---C=O group of the ester of **4v** was involved in the hydrogen bonding with the backbone NH of Gly37 (chain E) of the Aβ~42~ protofibril ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}a,b). In addition, π--π stacking interactions (0.48, 0.34, and 0.41 nm) between the triazole ring of **4v** and Phe19 (chain D) of the Aβ~42~ protofibril were observed ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}c). Notably, the π--π stacking interactions between the triazole ring of **4v** and Phe19 (chain D) lead to a reduced probability of π--π interactions between the aromatic residues of the Aβ~42~ protofibril. The interactions between the aromatic residues of the Aβ~42~ protofibril have been reported to play a key role in the generation of mature fibrils.^[@ref57]^ Thus, π--π stacking interactions between the triazole ring of **4v** and Phe19 (chain D) results in the diminished structural stability of the Aβ~42~ protofibril structure.

![The representative conformations of the most-populated clusters of the (a) Aβ~42~ protofibril and (b) Aβ~42~ protofibril--**4v** complex are shown in the cartoon representation with the percentage population of corresponding clusters.](ao0c01825_0012){#fig8}

![The key interactions of **4v** with Aβ~42~ protofibril in the representative member most-populated cluster of the Aβ~42~ protofibril--**4v** complex are shown in panel (a). A closer look of the hydrogen bond interaction between Gly37 (E) of the Aβ~42~ protofibril with the oxygen atom of the C=O group of the ester of **4v** is shown in panel (b), and π--π stacking interactions between Phe19 (D) Aβ~42~ protofibril with the triazole ring of **4v** is shown in panel (c).](ao0c01825_0013){#fig9}

### 3.2.3. Effect of **4v** on the Structural Stability of Aβ~42~ Protofibril Structure {#sec3.2.3}

The RMSD and *R*~g~ values were evaluated to get insights into the structural changes in the Aβ~42~ protofibril structure in the absence and presence of **4v** ([Figure S6](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)). The average value of the RMSD of the Aβ~42~ protofibril--**4v** complex was noted to be higher (0.50 nm) than the Aβ~42~ protofibril alone (0.45 nm), which indicates structural changes in the Aβ~42~ protofibril structure in the presence of **4v**. The average value of *R*~g~ was noted to be marginally higher in the Aβ~42~ protofibril--**4v** complex (1.47 nm) as compared to the Aβ~42~ protofibril alone (1.45 nm). For the Aβ~42~ protofibril structure, the time-dependent RMSD was plotted for the repeat simulations. A similar RMSD pattern was observed in the triplicate simulations, which highlight the reproducibility of MD simulations ([Figure S7](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)).

### 3.2.4. Effect of **4v** on the Secondary Structure of Aβ~42~ Protofibril {#sec3.2.4}

The secondary structure analysis highlighted that the Aβ~42~ protofibril sampled 32.7 ± 1.2% coil, 54.5 ± 1.9% β-sheet, 9.5 ± 0.6% bend, 0.2 ± 0.2% turn, and 3.0 ± 0% chain_separator conformations ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}). The repeat simulations of the Aβ~42~ protofibril showed almost similar secondary structure component statistics, which highlight the reproducibility of the MD simulation data ([Table S1](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)). In the Aβ~42~ protofibril--**4v** complex, a lower β-sheet (49.2 ± 0.8%) and higher coil (37.5 ± 0.6%) content was observed as compared to the Aβ~42~ protofibril alone. Barale et al. reported that Arg-Arg-7-amino-4-trifluoromethylcoumarin (RR-AFC), a short hybrid peptide, destabilized the Aβ~42~ protofibril structure by lowering the β-sheet content from 74 to 71%.^[@cit29b]^ Thus, a lower β-sheet content of the Aβ~42~ protofibril in the presence of **4v** indicated the destabilization of the Aβ~42~ protofibril structure.

![The evolution of the secondary structure as a function of simulation time (ns) for the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex is shown in panels (a) and (b), respectively. The secondary structure component statistics of the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex is shown in panel (c). The standard errors of the mean were calculated by dividing the simulation data into four long, non-overlapping blocks.](ao0c01825_0002){#fig10}

To visualize the Aβ~42~ protofibril destabilization in the presence of **4v**, the snapshots were taken at distinct time points ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}). During the course of the simulation, chains A--E of the Aβ~42~ protofibril were noted to be more scattered in the Aβ~42~ protofibril--**4v** complex as compared to the Aβ~42~ protofibril. Further, visual inspection depicts a decrease in the β-sheet content of chains A--E with a concomitant increase in the coil content in the Aβ~42~ protofibril--**4v** complex as compared to the Aβ~42~ protofibril. During the simulation, **4v** starts binding at the even edge (chain E) of the Aβ~42~ protofibril structure ([Figure [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"}b). The binding of **4v** at the even edge assumes significance as recent studies highlighted that the growth of the fibril structures is faster at the even edge due to the exposed CHC region.^[@ref61]^ At 150 ns, a significant loss in the β-sheet and enhancement in the coil content were observed in chains D and E of the Aβ~42~ protofibril in Aβ~42~ protofibril--**4v** complex as compared to the Aβ~42~ protofibril alone. The snapshots indicated that **4v** disrupts the Aβ~42~ protofibril structure by inserting into the hydrophobic core, which is in accordance with the earlier reports on the binding and destabilization of Aβ protofibril structure by small molecules such as wgx-50,^[@cit39c]^ dihydrochalcone,^[@ref62]^ and 12-crown-4 ether.^[@ref63]^

![The snapshots of MD trajectory at different time points for the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex are shown in panels (a) and (b), respectively. The Aβ~42~ protofibril is shown in the cartoon representation, and **4v** is shown in the stick representation.](ao0c01825_0003){#fig11}

### 3.2.5. Binding Free Energy Calculations Using MM-PBSA Analysis {#sec3.2.5}

The binding free energy (Δ*G*~binding~) between **4v** and Aβ~42~ protofibril was noted to be −83.7 ± 10.6 kcal/mol, which highlights favorable binding of **4v** with the Aβ~42~ protofibril ([Figure [12](#fig12){ref-type="fig"}](#fig12){ref-type="fig"}). Recently, we have reported *ΔG*~binding~ = −61.5 kcal/mol as energetically favorable for Aβ~42~ protofibril--**6n** complex formation.^[@cit29a]^ The critical analysis of the present results of mono-triazole-based compound **4v** with that of our previous study involving a di-triazole-based compound **6n** highlighted that the presence of substituents of varying electronic demands on the phenyl ring and other functional groups in the molecular scaffold governs the ligand--Aβ~42~ interactions. The non-bonded van der Waals interaction (Δ*E*~vdw~ = −52.7 ± 5.3 kcal/mol) and non-polar solvation energy (Δ*G*~nps~ = −46.9 ± 5.4 kcal/mol) favored the binding of **4v** with the Aβ~42~ protofibril. The dominance of van der Waals interactions in the binding of **4v** with the Aβ~42~ protofibril is consistent with the results reported by Ngo et al.,^[@ref64]^ which highlighted that these interactions play a significant role in the binding of curcumin, ibuprofen, and naproxen with Aβ~42~ fibrils. The per-residue binding free energy analysis highlighted that Val18 (chain C), Phe19 (chains C, D, and E), Gly37 (chain E), Gly38 (chain E), and Val39 (chain E) residues of the Aβ~42~ protofibril displayed the maximum contribution in the binding free energy. These results are consistent with clustering analysis, where **4v** displays hydrogen bonding with Gly37 (chain E) and π--π interactions with Phe19 (chain D) of the Aβ~42~ protofibril in the representative member of the most-populated conformational cluster.

![The binding free energy (kcal/mol) contribution of each residue of the Aβ~42~ protofibril in the Aβ~42~ protofibril--**4v** complex is shown in panel (a). A snapshot of the Aβ~42~ protofibril--**4v** complex depicting residues with high binding affinity with **4v** is shown. Various components of the binding free energy of the Aβ~42~ protofibril--**4v** complex are listed in panel (b).](ao0c01825_0004){#fig12}

The per-residue binding free energy analysis depicted that the residues of chains D and E of the Aβ~42~ protofibril were mainly involved in binding with **4v**. This in turn should affect the binding between the residues of chains D and E of the Aβ~42~ protofibril. In this regard, the binding free energy between chains D and E of the Aβ~42~ protofibril in the absence and presence of **4v** was evaluated ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). The higher binding affinity (*ΔG*~binding~*=* −167.1 ± 10.2 kcal/mol) between chains D and E of the Aβ~42~ protofibril structure in the Aβ~42~ protofibril alone as compared to the Aβ~42~ protofibril--**4v** complex (*ΔG*~binding~*=* −158.7 ± 21.8 kcal/mol) highlighted that **4v** disrupted the interchain interactions between chains D and E of the Aβ~42~ protofibril structure. The reduced binding affinity between different chains of the Aβ~42~ protofibril structure in the presence of **4v** is consistent with the results of Fan et al.,^[@cit39c]^ who reported that insertion of wgx-50 led to reduced binding affinity between Aβ~42~ protofibril chains and caused destabilization of the Aβ~42~ protofibril structure.

###### Binding Free Energy (kcal/mol) between Chains D and E of the Aβ~42~ Protofibril in the Absence and Presence of **4v**

  energy terms                                    interchain (chains D and E) binding free energy for the Aβ~42~ protofibril   interchain (chains D and E) binding free energy for the Aβ~42~ protofibril--**4v** complex
  ----------------------------------------------- ---------------------------------------------------------------------------- --------------------------------------------------------------------------------------------
  Δ*E*~vdw~                                       --99.9 ± 4.5                                                                 --89.4 ± 5.6
  Δ*E*~elec~                                      --6.0 ± 0.2                                                                  --22.7 ± 9.2
  Δ*E*~MM~[a](#t2fn1){ref-type="table-fn"}        --105.9 ± 4.7                                                                --112.1 ± 14.8
  Δ*G*~ps~                                        64.9 ± 12.8                                                                  71.5 ± 14.3
  Δ*G*~nps~                                       --126.1 ± 7.3                                                                --118.1 ± 7.3
  Δ*G*~solv~[b](#t2fn2){ref-type="table-fn"}      --61.2 ± 5.5                                                                 --46.6 ± 7.0
  Δ*G*~binding~[c](#t2fn3){ref-type="table-fn"}   --167.1 ± 10.2                                                               --158.7 ± 21.8

Δ*E*~MM~ = Δ*E*~vdw~ + Δ*E*~elec~.

Δ*G*~solv~ = Δ*G*~ps~ + Δ*G*~nps~.

Δ*G*~binding~ = Δ*E*~MM~ + Δ*G*~sol~.

### 3.2.6. Impact of **4v** on the Tertiary Contacts between Residues of Chains D and E of Aβ~42~ Protofibril {#sec3.2.6}

The conformational clustering analysis highlighted that **4v** binds with the residues of chains D and E of the Aβ~42~ protofibril structure. Thus, residue--residue contact map of chains D and E of the Aβ~42~ protofibril was plotted in the absence and presence of **4v** ([Figure S8](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf)). A significant loss of residue--residue contacts between chains D and E in the Aβ~42~ protofibril--**4v** complex was observed as compared to the Aβ~42~ protofibril, which was consistent with the binding free energy analysis between chains D and E of the Aβ~42~ protofibril. The reduced tertiary contacts between residues of chains D and E depict destabilization of the Aβ~42~ protofibril by **4v**.

### 3.2.7. Impact of **4v** on the FEL of Aβ~42~ Protofibril {#sec3.2.7}

The FEL depicts three dominant minimum energy basins in the Aβ~42~ protofibril, whereas two energy minima were observed in the Aβ~42~ protofibril--**4v** complex ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}). From each minimum energy basin of the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex, the conformations were extracted and secondary structure analysis was performed ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}c). In the Aβ~42~ protofibril, the minimum energy conformations *S1*, *S2*, and *S3* sampled 33, 30, and 31% coil and 51, 53, and 53% β-sheet content, respectively. In comparison, the minimum energy conformations *S1* and *S2* extracted from the FEL of the Aβ~42~ protofibril--**4v** complex depict higher percentages of coil content (40 and 44%) and lower β-sheet contents (48 and 43%). A lower β-sheet content observed in minimum energy conformations extracted from the FEL of the Aβ~42~ protofibril--**4v** complex indicates destabilization of the Aβ~42~ protofibril by **4v**. The MD results highlighted that **4v** interacts with the residues of chains D and E of the Aβ~42~ protofibril and leads to the disruption of the Aβ~42~ protofibril structure by lowering the binding affinity between the two chains. These results help in understanding the experimentally observed disaggregation of preformed Aβ~42~ fibrils in the presence of **4v**.^[@ref21]^

![The FEL of the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex are shown in panels (a) and (b), respectively. The representative structures of the minimum energy basins are shown in the cartoon representation. The secondary structure component statistics of the minimum energy conformations obtained in the FEL of the Aβ~42~ protofibril and Aβ~42~ protofibril--**4v** complex is listed in panel (c).](ao0c01825_0005){#fig13}

4. Conclusions {#sec4}
==============

In a recent experimental study, we have reported a library of multifunctional triazole-based compounds **4(a**--**x)** that target four major Alzheimer's disease (AD) hallmarks: Aβ~42~ aggregation, Aβ~42~ disaggregation, Cu^2+^-induced Aβ~42~ aggregation, and reactive oxygen species (ROS) generation. Among the designed library, **4v** showed the most potent inhibitory activity against amyloid aggregation. In the present study, we have performed extensive molecular dynamics (MD) simulations to identify the inhibitory mechanism of **4v** against Aβ~42~ aggregation and disaggregation of preformed Aβ~42~ fibrils. The MD studies highlighted that **4v** preferably binds at the central hydrophobic core (CHC) region of the Aβ~42~ monomer and causes large structural perturbations in the structure of the Aβ~42~ monomer. The dictionary of secondary structure of proteins (DSSP) analysis highlighted that the helical content increases (27--33%) and β-sheet content decreases considerably (9--3%) for the Aβ~42~ monomer in the presence of **4v**. Thus, **4v** retards the conformation conversion of the Aβ~42~ monomer from helical to β-sheet conformation. The binding free energy calculated by the MM-PBSA method revealed an energetically favorable process with *ΔG*~binding~ = −44.9 ± 3.3 kcal/mol for the Aβ~42~ monomer--**4v** complex. The per-residue binding free energy analysis revealed the maximum contribution of Phe19 and Phe20 of the Aβ~42~ monomer in binding to **4v**. This indicates the non-availability of these residues for π--π interactions, which in turn highlight a lower aggregation tendency of Aβ~42~ in the presence of **4v**.

In the Aβ~42~ protofibril--**4v** complex, **4v** binds at the even edge (chain E) of the Aβ~42~ protofibril, which plays critical role in the growth of the fibril assembly. In the Aβ~42~ protofibril--**4v** complex, the destabilization occurred by reduction of β-sheet content and an increase in coil content. The clustering analysis highlighted that **4v** interacts with chains D and E of the Aβ~42~ protofibril by hydrogen bonding and π--π interactions. The reduced binding free energy and tertiary contacts between chains D and E of the Aβ~42~ protofibril in the presence of **4v** highlighted the destabilization of the Aβ~42~ protofibril structure. Thus, MD simulations highlighted that **4v** successfully hindered the Aβ~42~ aggregation and disintegrated the Aβ~42~ protofibril structure, which are in agreement with the experimental observations. The results of the present study have excavated our understanding of the molecular-level details of the inhibition mechanism of **4v** against Aβ~42~ aggregation and protofibril destabilization and thus opens up new avenues in designing triazole-based scaffolds as potent inhibitors of amyloid aggregation in AD.

The Supporting Information is available free of charge at [https://pubs.acs.org/doi/10.1021/acsomega.0c01825](https://pubs.acs.org/doi/10.1021/acsomega.0c01825?goto=supporting-info).Figures S1--S8 and Table S1 representing data for RMSD, RMSF, *R*~g~, 2D LigPlot^+^ map, correlation between simulated and experimental NMR chemical shifts, ^3^*J*~NH--Hα~ coupling constants values of the Aβ~42~ monomer and Aβ~42~ protofibril residues obtained from the simulation and experimental data, residue--residue contacts between chains D and E of the Aβ~42~ protofibril, and RMSD and secondary structure component statistics for the repeat simulations ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c01825/suppl_file/ao0c01825_si_001.pdf))
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